Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-08-27 Purchase |
2024-08-29 4:30 pm |
ENDRA Life Sciences Inc. | NDRA | UBS Group AG 10% Owner |
3,715 | $0.5523 | $2,052 | 146,012 (Indirect) |
View |
| 2023-05-18 Purchase |
2023-05-22 07:30 am |
ENDRA Life Sciences Inc. | NDRA | Thornton Michael Milos Chief Technology Officer |
15,000 | $1.65 | $24,750 | 34,139 (Direct) |
View |
| 2023-05-02 Purchase |
2023-05-03 4:07 pm |
ENDRA Life Sciences Inc. | NDRA | DIGIANDOMENICO ANTHONY Director |
83,333 | $1.2 | $100,000 | 144,101 (Direct) |
View |
| 2022-12-09 Purchase |
2022-12-13 4:00 pm |
ENDRA Life Sciences Inc. | NDRA | Thornton Michael Milos Chief Technology Officer |
1,500 | $3.4 | $5,100 | 19,139 (Direct) |
View |
| 2022-11-23 Purchase |
2022-11-28 5:00 pm |
ENDRA Life Sciences Inc. | NDRA | Tokman Alexander Y Director |
10,000 | $0.17 | $1,700 | 162,857 (Direct) |
View |
| 2022-08-22 Purchase |
2022-08-24 08:57 am |
ENDRA Life Sciences Inc. | NDRA | Thornton Michael Milos Chief Technology Officer |
20,000 | $0.27 | $5,400 | 352,775 (Direct) |
View |
| 2022-08-22 Purchase |
2022-08-24 08:55 am |
ENDRA Life Sciences Inc. | NDRA | Tokman Alexander Y Director |
20,000 | $0.26 | $5,200 | 152,857 (Direct) |
View |
| 2022-05-26 Purchase |
2022-05-31 08:46 am |
ENDRA Life Sciences Inc. | NDRA | Thornton Michael Milos Chief Technology Officer |
25,000 | $0.21 | $5,250 | 332,775 (Direct) |
View |
| 2022-05-18 Purchase |
2022-05-23 4:30 pm |
ENDRA Life Sciences Inc. | NDRA | Thornton Michael Milos Chief Technology Officer |
25,000 | $0.22 | $5,500 | 307,775 (Direct) |
View |
| 2022-05-17 Purchase |
2022-05-19 07:00 am |
ENDRA Life Sciences Inc. | NDRA | Michelon Francois Roger Chief Executive Officer |
5,100 | $0.19 | $969 | 97,191 (Direct) |
View |
| 2022-05-16 Purchase |
2022-05-17 4:14 pm |
ENDRA Life Sciences Inc. | NDRA | Tokman Alexander Y Director |
100,000 | $0.1963 | $19,630 | 132,857 (Direct) |
View |
| 2021-08-25 Sale |
2021-08-27 4:15 pm |
ENDRA Life Sciences Inc. | NDRA | Basenese Lou Director |
50,000 | $1.832 | $91,600 | 49,068 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership(A) |
2024-09-05 2:47 pm |
N/A N/A |
ENDRA Life Sciences Inc. | NDRA | UBS Group AG Market maker/broker-dealer |
0 | $0 | 146,012 (Indirect) |
View |
Ownership |
2024-08-29 12:11 pm |
N/A N/A |
ENDRA Life Sciences Inc. | NDRA | UBS Group AG 10% Owner |
0 | $0 | 146,012 (Indirect) |
View |
| 2024-01-02 Option Award |
2024-02-23 5:00 pm |
N/A 2034-01-02 |
ENDRA Life Sciences Inc. | NDRA | Basenese Lou Director |
600 | $0 | 600 (Direct) |
View |
| 2024-01-02 Option Award |
2024-02-23 5:00 pm |
N/A 2034-01-02 |
ENDRA Life Sciences Inc. | NDRA | Harsh Michael Director |
600 | $0 | 600 (Direct) |
View |
| 2024-01-02 Option Award |
2024-02-23 5:00 pm |
N/A 2034-01-02 |
ENDRA Life Sciences Inc. | NDRA | DIGIANDOMENICO ANTHONY Director |
600 | $0 | 600 (Direct) |
View |
| 2024-01-02 Option Award |
2024-02-23 5:00 pm |
N/A 2034-01-02 |
ENDRA Life Sciences Inc. | NDRA | Tokman Alexander Y Director |
600 | $0 | 600 (Direct) |
View |
| 2023-01-30 Option Award |
2023-02-01 8:30 pm |
N/A 2033-01-30 |
ENDRA Life Sciences Inc. | NDRA | Basenese Lou Director |
6,746 | $0 | 6,746 (Direct) |
View |
| 2023-01-30 Option Award |
2023-02-01 8:30 pm |
N/A 2033-01-30 |
ENDRA Life Sciences Inc. | NDRA | Tokman Alexander Y Director |
9,621 | $0 | 9,621 (Direct) |
View |
| 2023-01-30 Option Award |
2023-02-01 8:30 pm |
N/A 2033-01-30 |
ENDRA Life Sciences Inc. | NDRA | Harsh Michael Director |
9,634 | $0 | 9,634 (Direct) |
View |
| 2023-01-30 Option Award |
2023-02-01 8:30 pm |
N/A 2033-01-30 |
ENDRA Life Sciences Inc. | NDRA | DIGIANDOMENICO ANTHONY Director |
9,621 | $0 | 9,621 (Direct) |
View |
| 2023-01-30 Option Award |
2023-02-01 8:30 pm |
N/A 2033-01-30 |
ENDRA Life Sciences Inc. | NDRA | Pestrikova Irina Senior Director, Finance |
8,000 | $0 | 8,000 (Direct) |
View |
| 2023-01-30 Option Award |
2023-02-01 8:30 pm |
N/A 2033-01-30 |
ENDRA Life Sciences Inc. | NDRA | Thornton Michael Milos Chief Technology Officer |
68,066 | $0 | 68,066 (Direct) |
View |
| 2023-01-30 Option Award |
2023-02-01 8:30 pm |
N/A 2033-01-30 |
ENDRA Life Sciences Inc. | NDRA | Michelon Francois Roger Chief Executive Officer |
69,531 | $0 | 69,531 (Direct) |
View |
| 2022-03-28 Option Award |
2022-03-30 5:16 pm |
N/A 2032-03-28 |
ENDRA Life Sciences Inc. | NDRA | Maloberti Renaud Bertrand Chief Commercial Officer |
186,430 | $0 | 186,430 (Direct) |
View |
| 2022-03-28 Option Award |
2022-03-30 5:15 pm |
N/A 2032-03-28 |
ENDRA Life Sciences Inc. | NDRA | Thornton Michael Milos Chief Technology Officer |
698,102 | $0 | 698,102 (Direct) |
View |
| 2022-03-28 Option Award |
2022-03-30 5:15 pm |
N/A 2032-03-28 |
ENDRA Life Sciences Inc. | NDRA | Michelon Francois Roger Chief Executive Officer |
713,132 | $0 | 713,132 (Direct) |
View |
| 2022-03-28 Option Award |
2022-03-30 5:15 pm |
N/A 2032-03-28 |
ENDRA Life Sciences Inc. | NDRA | Tokman Alexander Y Director |
109,323 | $0 | 109,323 (Direct) |
View |
| 2022-03-28 Option Award |
2022-03-30 5:15 pm |
N/A 2032-03-28 |
ENDRA Life Sciences Inc. | NDRA | DIGIANDOMENICO ANTHONY Director |
109,323 | $0 | 109,323 (Direct) |
View |
| 2022-03-28 Option Award |
2022-03-30 5:15 pm |
N/A 2032-03-28 |
ENDRA Life Sciences Inc. | NDRA | Pestrikova Irina Senior Director, Finance |
41,500 | $0 | 41,500 (Direct) |
View |
| 2022-03-28 Option Award |
2022-03-30 5:15 pm |
N/A 2032-03-28 |
ENDRA Life Sciences Inc. | NDRA | Harsh Michael Director |
109,492 | $0 | 109,492 (Direct) |
View |
| 2022-03-28 Option Award |
2022-03-30 5:15 pm |
N/A 2032-03-28 |
ENDRA Life Sciences Inc. | NDRA | Basenese Lou Director |
74,500 | $0 | 74,500 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-04 5:07 pm |
2023-01-03 2032-01-03 |
ENDRA Life Sciences Inc. | NDRA | Tokman Alexander Y Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-04 5:06 pm |
2023-01-03 2032-01-03 |
ENDRA Life Sciences Inc. | NDRA | DIGIANDOMENICO ANTHONY Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-04 5:05 pm |
2023-01-03 2032-01-03 |
ENDRA Life Sciences Inc. | NDRA | Harsh Michael Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-04 5:03 pm |
2023-01-03 2032-01-03 |
ENDRA Life Sciences Inc. | NDRA | Basenese Lou Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2021-01-28 Option Award |
2021-09-22 4:05 pm |
N/A N/A |
ENDRA Life Sciences Inc. | NDRA | Thornton Michael Milos Chief Technology Officer |
22,815 | $0 | 316,525 (Direct) |
View |